Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Kewaunee Scientific VP sells shares worth over $92,000

Published 15/03/2024, 20:56
Updated 15/03/2024, 20:56
© Reuters.

In a recent transaction, Mandar Ranade, the Vice President of Information Technology at Kewaunee Scientific Corp (NASDAQ:KEQU), has sold a total of 3,000 shares of the company's common stock. The sale, which took place on March 14, 2024, amounted to a total value of $92,550, with the shares being sold at a weighted average price of $30.85 each.

The sale was executed in multiple transactions at prices that ranged from $30.76 to $31.25 per share. Following this sale, Ranade's direct holdings in the company amount to 9,175 shares of common stock.

Kewaunee Scientific Corp, known for its laboratory apparatus and furniture, is a company with a long history in the industry. The transaction details indicate a notable change in the insider's stake in the company, which is of interest to investors keeping an eye on insider activities.

Investors and followers of Kewaunee Scientific Corp can request detailed information about the sale, including the number of shares sold at each price point within the provided range, from either the company, its security holders, or the SEC staff, as per the reporting person's undertaking.

This recent stock sale by a high-ranking executive at Kewaunee Scientific Corp is a transaction that could be significant to shareholders and potential investors, providing insights into insider confidence and company valuation.

InvestingPro Insights

Following the recent stock sale by Mandar Ranade, Vice President of Information Technology at Kewaunee Scientific Corp, investors may gain additional perspective through key metrics and insights from InvestingPro. As of the last twelve months leading up to Q3 2024, Kewaunee Scientific Corp has demonstrated a strong financial standing with a market capitalization of approximately $90.57 million and a P/E ratio that stands at 10.37, indicating a potentially attractive valuation for investors.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

One of the notable InvestingPro Tips for Kewaunee Scientific Corp is its high shareholder yield, which is a composite measure of shareholder return. Additionally, the company's valuation implies a strong free cash flow yield, suggesting that it may generate sufficient cash relative to its share price. This could be particularly relevant for investors looking for companies with the potential for robust cash flow generation.

From the data provided, Kewaunee Scientific Corp has also been trading near its 52-week high, with a price percentage of 96.31% of the high mark. This performance is complemented by a significant return over the last year, with a 92.25% price total return. Such metrics may indicate a positive market sentiment and a sustained upward trend in the company's stock price.

For investors interested in a deeper dive into Kewaunee Scientific Corp's financials and performance, additional InvestingPro Tips are available, providing a comprehensive analysis of the company. With the use of coupon code PRONEWS24, investors can receive an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking access to a total of 11 InvestingPro Tips for Kewaunee Scientific Corp.

Considering the recent insider transaction and the company's current financial metrics, these insights could prove invaluable for those looking to make informed decisions regarding their investments in Kewaunee Scientific Corp.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.